SCHEMBL4492562

SCHEMBL4492562

CN(C)CC(=O)N(C)c1ccc(NC(=C2C(=O)Nc3cc(F)ccc32)c2ccc(N3CCOC3=O)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELOVL6 Q9H5J4 1/20 0.37
KDM1A O60341 4/20 0.36
MAOA P21397 4/20 0.36
MAOB P27338 4/20 0.36
RCOR1 Q9UKL0 4/20 0.36
BACE1 P56817 1/20 0.33
KDM1B Q8NB78 2/20 0.32
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALOX15 P16050 1/20 0.31
ALOX12 P18054 1/20 0.31
MAPK1 P28482 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
PDGFRB P09619 1/20 0.31
RAF1 P04049 1/20 0.31
CCNA2 P20248 3/20 0.30
CDK2 P24941 3/20 0.30
CCNA1 P78396 3/20 0.30
FLT3 P36888 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4492558 1.00 ELOVL6 (0.37) ELOVL6KDM1AMAOAMAOBRCOR1
SCHEMBL4498268 0.91 KDM1A (0.36) ELOVL6KDM1AMAOAMAOBRCOR1
SCHEMBL4498266 0.91 KDM1A (0.36) ELOVL6KDM1AMAOAMAOBRCOR1
SCHEMBL4499816 0.89 AAK1 (0.39) ELOVL6KDM1AMAOAMAOBRCOR1
SCHEMBL4499819 0.89 AAK1 (0.39) ELOVL6KDM1AMAOAMAOBRCOR1
SCHEMBL4492556 0.88 KDM1A (0.37) ELOVL6KDM1AMAOAMAOBRCOR1
SCHEMBL4483327 0.87 ELOVL6 (0.37) ELOVL6KDM1AMAOAMAOBRCOR1
SCHEMBL4483330 0.87 ELOVL6 (0.37) ELOVL6KDM1AMAOAMAOBRCOR1
SCHEMBL4491900 0.87 ELOVL6 (0.36) ELOVL6KDM1AMAOAMAOBRCOR1
SCHEMBL4491904 0.87 ELOVL6 (0.36) ELOVL6KDM1AMAOAMAOBRCOR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR ELOVL6 2925/4885KDM1A 1808/4885MAOA 822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.